{
    "title": "FDA declines to approve ImmunityBio's bladder cancer therapy, shares slump",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12072441/Immunitybio-slumps-FDA-declines-approve-bladder-cancer-treatment.html",
    "date": "2023-05-11",
    "keywords": [
        "therapy",
        "combination",
        "application",
        "company",
        "bladder",
        "cancer",
        "companys",
        "immunitybio",
        "letter",
        "health",
        "regulator",
        "manufacturing",
        "fda",
        "safety",
        "inc",
        "thursday",
        "food",
        "drug",
        "administration",
        "type",
        "developer",
        "premarket",
        "trading",
        "filing",
        "exchange",
        "commission",
        "ability",
        "business",
        "anktiva",
        "bacillus",
        "calmettegu\u00e9rin",
        "vaccine",
        "tuberculosis",
        "nonmuscle",
        "tuesday",
        "inspection",
        "thirdparty",
        "contract",
        "form",
        "efficacy",
        "update",
        "resubmission",
        "meeting",
        "matter",
        "approval",
        "partner",
        "commercialization",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "koyyur",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}